Gregory D. Plowman
Direttore/Membro del Consiglio presso New York Biotechnology Association, Inc.
Profilo
Gregory D.
Plowman is currently a Director at New York Biotechnology Association, Inc., AurKa Pharma, Inc., and Acanthas Pharma, Inc. He was previously a Senior Vice President at ImClone LLC, Vice President-Oncology Research at Eli Lilly & Co., and Chief Technology Officer at Exelixis, Inc. Plowman holds a doctorate from the University of Washington and an undergraduate degree from Whitman College.
Posizioni attive di Gregory D. Plowman
| Società | Posizione | Inizio |
|---|---|---|
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Direttore/Membro del Consiglio | - |
AurKa Pharma, Inc.
 AurKa Pharma, Inc. BiotechnologyHealth Technology AurKa Pharma, Inc. develops medication for cancer treatment. The company was founded by Caroline Fortier and is headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | - |
Acanthas Pharma, Inc.
 Acanthas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Acanthas Pharma, Inc. manufactures pharmaceutical products. The company is headquartered in Montréal, Canada. | Direttore/Membro del Consiglio | 19/03/2019 |
Precedenti posizioni note di Gregory D. Plowman
| Società | Posizione | Fine |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
| EXELIXIS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Gregory D. Plowman
| University of Washington | Doctorate Degree |
| Whitman College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| EXELIXIS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Commercial Services |
AurKa Pharma, Inc.
AurKa Pharma, Inc. BiotechnologyHealth Technology AurKa Pharma, Inc. develops medication for cancer treatment. The company was founded by Caroline Fortier and is headquartered in Montreal, Canada. | Health Technology |
Acanthas Pharma, Inc.
Acanthas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Acanthas Pharma, Inc. manufactures pharmaceutical products. The company is headquartered in Montréal, Canada. | Health Technology |
- Borsa valori
- Insiders
- Gregory D. Plowman
